Tay-Sachs Disease Treatment Global Market Report 2025
상품코드:1826999
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
테이삭스병 치료 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 22억 8,000만 달러, 2025년에는 24억 5,000만 달러에 달하고, CAGR 7.2%로 성장할 전망입니다. 성과 기간의 성장은 유전자 스크리닝 증가, 희귀질환에 대한 관심 증가, 고품질의 건강 관리에 대한 수요 증가, 테이삭스병의 사례 증가, 만성 질환의 사례 증가에 기인합니다.
테이삭스병 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 32억 3,000만 달러로 성장하고, CAGR은 7.2%를 나타낼 전망입니다. 예측기간의 성장은 리소좀 저장장애의 유병률 상승, 계발활동 확대, 유전자검사서비스 확대, 대증요법에 대한 수요 증가, 유전병의 유병률 상승으로 인한 것으로 예측됩니다. 예측 기간의 주요 동향으로는 유전자 치료의 진보, 비용 효과적인 차세대 시퀀싱, 자동 복제 플랫폼, 약물전달 시스템 개발, AI와 머신러닝 통합, 원격 의료 솔루션 채택 등이 있습니다.
테이삭스병 치료는 헥소사미니다제 A(Hex-A)라는 효소의 결손으로 인한 이 드문 유전성 질환을 관리하고 치유의 가능성을 목표로 하는 치료 접근법을 포함하고 있습니다. 현재의 치료에는 실험적 유전자 요법, 기질 제거 요법 및 증상을 완화시키고 이를 앓고 있는 환자의 QOL을 개선하기 위한 지지 요법이 포함됩니다.
테이삭스병의 주요 치료법으로는 약물요법, 호흡케어, 물리치료가 있습니다. 약물 요법은 통증, 발작, 근강강 및 관련 합병증을 치료함으로써 증상을 완화하고 질병 진행을 늦추고 환자의 편안함을 높이기 위해 고안된 처방약을 사용합니다. 이러한 치료는 주사, 경구 등 다양한 방법으로 이루어져 병원, 재택 케어, 전문 클리닉 등에서 이용되고 있습니다.
2025년 봄 미국 관세의 급상승과 이에 따른 무역 마찰은 의료 분야, 특히 필수적인 의료기기, 진단 장비 및 의약품 공급에 큰 영향을 미쳤습니다. 병원과 건강 관리 제공업체는 수입되는 수술 기구, 영상 진단 시스템, 주사기 및 카테터와 같은 소모품의 비용 상승에 시달리고 있으며, 그 대부분은 국내 대체품이 제한되어 있습니다. 이러한 비용 상승이 의료 예산을 압박하기 때문에 일부 의료기관은 장비 업그레이드를 늦추거나 비용 증가를 환자에게 전가하고 있습니다. 게다가 원료와 부품에 대한 관세는 중요한 의약품과 의료기기의 제조에 지장을 주고 공급망의 지연으로 이어지고 있습니다. 이에 비해 업계는 다양한 조달 전략을 채택하고 가능한 한 현지 생산을 확대하고 중요한 의료 제품의 관세 면제를 수행하고 있습니다.
이 조사 보고서는 테이삭스 병 치료 산업 세계 시장 규모, 지역 점유율, 테이삭스 병 치료 시장 점유율을 가진 경쟁업체, 상세한 테이삭스 병 치료 시장 부문, 시장 동향 및 비즈니스 기회, 테이삭스 병 치료 업계에서 성공하기 위해 필요한 데이터 등 테이삭스 병 치료 시장 통계를 제공하는 The Business Research Company의 신간 보고서 시리즈 중 하나입니다. 이 테이삭스 병 치료 시장 조사 보고서는 업계의 현재 및 미래 시나리오를 자세히 분석하고 필요한 모든 것에 대한 완전한 전망을 제공합니다.
향후 5년간의 성장률 7.2%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 프랑스와 영국에서 수입되는 효소 보충 요법과 유전자 검사 키트의 비용을 증가시키고 조기 개입을 손상시키고 소아 신경학의 비용을 증가시킬 수 있으므로 희귀질환 관리를 혼란시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
유전성 질환의 유병률 증가는 테이삭스병 치료 시장의 진보를 촉진할 것으로 예측됩니다. 유전성 질환은 유전성 또는 자연 돌연변이로 인한 개인의 DNA 이상으로 인한 것입니다. 이러한 질병 증가는 진단 방법의 개선, 의식 증가, 환경 요인, 육아 지연 및 라이프 스타일의 변화와 관련된 돌연변이 증가로 인한 것입니다. 유전성 질환 증가는 유전자 치료, 효소 보충, 조기 진단 연구에 박차를 가하고 테이삭스병 치료의 진보의 필요성을 강조하고 있습니다. 예를 들어, 2022년 2월 영국 정부 기관인 제노믹스 잉글랜드는 7,000개가 넘는 희귀질환이 인정되었으며, 영국에서는 약 17명 중 1명(350만 명)이 병을 앓고 있다고 보고했습니다. 그 결과, 유전성 질환의 유병률의 상승은 테이삭스병 치료 시장을 전진시킬 것으로 예측됩니다.
테이삭스병 치료 시장의 주요 기업은 유전자 치료, 효소 보충, 저분자 의약품 등 환자의 예후를 개선할 수 있는 치료법을 탐구하기 위해 임상시험을 포함한 혁신적인 치료에 주력하고 있습니다. 임상시험은 인간의 치료, 약물, 치료의 안전성, 효능 및 잠재적 부작용을 평가하는 조사 연구입니다. 예를 들어, 2024년 7월 미국 바이오의약품회사인 인트라바이오사는 GM2 강글리오시도시스(테이삭스병, 샌드호프병)를 타겟으로 한 IB1001의 임상시험(IB1001-202)을 실시하기 위한 시험약(IND) 신청에 대해 미국 식품의약국 이 임상시험은 미국, 영국, 독일, 스페인에서 실시되었으며 현재 치료법이 승인되지 않은 이러한 치명적인 신경 퇴행성 질환을 다룹니다. 인트라 바이오의 회장은 이러한 쇠약 상태에 효과적인 치료법의 개발이 시급하다고 강조했습니다.
2023년 6월 미국의 비영리 연구기관인 뉴호프 리서치 파운데이션사는 포지 바이오로직스사와 제휴하여 혁신적인 유전자 치료제 NHR01을 테이삭스병과 GM2 강글리오시도시스 환자를 대상으로 한 I/II상 임상시험으로 진행합니다. 미국을 기반으로 하는 생명공학기업인 포지 바이오로직스는 유전자 치료의 수탁 제조와 임상 단계의 치료제를 전문으로 하고 있습니다.
테이삭스병 치료 시장은 호흡 케어, 물리치료, 유전 상담, 재택 케어 서비스 등의 서비스를 제공함으로써 얻을 수 있는 수익으로 구성되어 있습니다. 시장 가치에는 서비스 제공업체가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 테이삭스병 치료 시장에는 항경련제, 유전자 치료 제품, 지지 요법 제품, 진단 도구의 판매가 포함됩니다. 이 시장의 가치는 "Factory Gate"가치, 즉 다른 기업(다운스트림 제조업자, 도매업체, 유통업체, 소매업체 포함)이든 직접 최종 고객이든, 상품 제조업체 또는 제작자가 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품 제작자에 의해 판매되는 관련 서비스도 포함됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 테이삭스병 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계 테이삭스병 치료 시장 : 성장률 분석
세계 테이삭스병 치료 시장 실적 : 규모와 성장, 2019-2024
세계 테이삭스병 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 테이삭스병 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 테이삭스병 치료 시장 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
약
호흡 케어
물리치료
세계의 테이삭스병 치료 시장 투여 방법별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
주사제
오랄
기타 투여 방법
세계 테이삭스병 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
홈케어
전문 클리닉
기타 최종 사용자
세계의 테이삭스병 치료 시장 : 세분화 약유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
항 간질 약
Miglustat
대증요법의 지지요법
세계의 테이삭스병 치료 시장 : 세분화 호흡 케어(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
기계적 인공호흡기
기도 클리어런스 요법
산소요법
세계의 테이삭스병 치료 시장 : 세분화 물리치료(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
운동기능훈련
하이드로테라피
이동 보조 장치
제7장 지역별/국가별 분석
세계의 테이삭스병 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 테이삭스병 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
테이삭스병 치료 시장 :경쟁 구도
테이삭스병 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Takeda Pharmaceutical Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Regeneron Pharmaceuticals Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Biogen Inc.
Vertex Pharmaceuticals Incorporated
BioMarin Pharmaceutical Inc.
Sarepta Therapeutics Inc.
Ultragenyx Pharmaceutical Inc.
Amicus Therapeutics Inc.
Spark Therapeutics Inc.
Rocket Pharmaceuticals Inc.
RegenxBio Inc.
Forge Biologics Inc.
Passage Bio Inc.
Protalix BioTherapeutics Inc.
Orchard Therapeutics plc
Affinia Therapeutics Inc.
IntraBio Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
테이삭스병 치료 시장 2029 : 새로운 기회를 제공하는 국가
테이삭스병 치료 시장 2029 : 새로운 기회를 제공하는 부문
테이삭스병 치료 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Tay-Sachs disease treatment encompasses therapeutic approaches aimed at managing or potentially curing this rare genetic disorder caused by a deficiency of the enzyme hexosaminidase A (Hex-A). Current treatment efforts include experimental gene therapy, substrate reduction therapy, and supportive care to alleviate symptoms and improve the quality of life for affected individuals.
The primary treatment options for Tay-Sachs disease include medication, respiratory care, and physical therapy. Medication involves prescribed drugs designed to relieve symptoms, slow disease progression, and enhance patient comfort by addressing pain, seizures, muscle stiffness, and related complications. These treatments are administered through various modes, including injectable, oral, and other methods, and are utilized in hospitals, homecare settings, and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The tay-sachs disease treatment market research report is one of a series of new reports from The Business Research Company that provides tay-sachs disease treatment market statistics, including the tay-sachs disease treatment industry's global market size, regional shares, competitors with a tay-sachs disease treatment market share, detailed tay-sachs disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tay-sachs disease treatment industry. This tay-sachs disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The tay-sachs disease treatment market size has grown strongly in recent years. It will grow from $2.28 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increase in genetic screening, increase focus on rare diseases, rise in demand for quality healthcare, rise in cases of tay-sachs disease, and rise in chronic condition cases.
The tay-sachs disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to rising prevalence of lysosomal storage disorders, growing awareness initiatives, expansion of genetic testing services, growing demand for symptomatic treatments, and rising prevalence of genetic diseases. Major trends in the forecast period include advancements in gene therapy, cost-effective next-generation sequencing, automated cloning platforms, developments in drug delivery systems, integration of AI and machine learning, and adoption of telemedicine solutions.
The forecast of 7.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt rare disease management by increasing costs for enzyme replacement therapies and genetic testing kits imported from France and the UK, potentially compromising early intervention and increasing pediatric neurology expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of genetic diseases is expected to drive advancements in the Tay-Sachs disease treatment market. Genetic diseases result from abnormalities in an individual's DNA, either inherited or caused by spontaneous mutations. The rise in these conditions is attributed to improved diagnostics, heightened awareness, environmental factors, and higher mutation rates associated with delayed parenthood and lifestyle changes. The growing occurrence of genetic diseases underscores the need for advancements in Tay-Sachs disease treatment, fueling research in gene therapy, enzyme replacement, and early diagnostics. For example, in February 2022, Genomics England, a UK-based government organization, reported that over 7,000 recognized rare diseases affect approximately 1 in 17 people (3.5 million) in the UK. Consequently, the rising prevalence of genetic diseases is expected to drive the Tay-Sachs disease treatment market forward.
Leading companies in the Tay-Sachs disease treatment market are focusing on innovative therapies, including clinical trials, to explore potential treatments such as gene therapy, enzyme replacement, and small-molecule drugs for improved patient outcomes. Clinical trials are research studies that assess the safety, effectiveness, and potential side effects of medical treatments, drugs, or procedures in humans. For instance, in July 2024, IntraBio Inc., a US-based biopharmaceutical company, announced that it had received US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) Application to conduct a clinical trial (IB1001-202) for IB1001, targeting GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease). The trial is being conducted in the U.S., UK, Germany, and Spain to address these fatal neurodegenerative disorders, which currently have no approved treatments. IntraBio's chairman emphasized the urgent need to develop effective therapies for these debilitating conditions.
In June 2023, New Hope Research Foundation Inc., a US-based non-profit research organization, partnered with Forge Biologics Inc. to advance its innovative gene therapy, NHR01, into Phase I/II clinical trials for patients with Tay-Sachs disease and GM2 gangliosidosis. Forge Biologics, a US-based biotechnology company, specializes in gene therapy contract manufacturing and clinical-stage therapeutics.
Major players in the tay-sachs disease treatment market are Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Amicus Therapeutics Inc., Spark Therapeutics Inc., Rocket Pharmaceuticals Inc., RegenxBio Inc., Forge Biologics Inc., Passage Bio Inc., Protalix BioTherapeutics Inc., Orchard Therapeutics plc, Affinia Therapeutics Inc., IntraBio Inc., and Taysha Gene Therapies Inc.
North America was the largest region in the tay-sachs disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tay-sachs disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tay-sachs disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tay-sachs disease treatment market consists of revenues earned by providing services such as respiratory care, physical therapy, genetic counseling, and home care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The tay-sachs disease treatment market includes sales of anticonvulsants, gene therapy products, supportive care products, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tay-Sachs Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tay-sachs disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tay-sachs disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tay-sachs disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Medication; Respiratory Care; Physical Therapy
2) By Mode Of Administration: Injectable; Oral; Other Mode Of Administration
3) By End-Users: Hospitals; Homecare; Specialty Clinics
Subsegments:
1) By Medication: Antiepileptic Drugs; Miglustat; Supportive Symptomatic Medications
3. Tay-Sachs Disease Treatment Market Trends And Strategies
4. Tay-Sachs Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Tay-Sachs Disease Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Tay-Sachs Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tay-Sachs Disease Treatment Market Growth Rate Analysis
5.4. Global Tay-Sachs Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tay-Sachs Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tay-Sachs Disease Treatment Total Addressable Market (TAM)
6.1. Global Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Respiratory Care
Physical Therapy
6.2. Global Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Oral
Other Mode Of Administration
6.3. Global Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End User
6.4. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiepileptic Drugs
Miglustat
Supportive Symptomatic Medications
6.5. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Respiratory Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechanical Ventilation
Airway Clearance Therapy
Oxygen Therapy
6.6. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Motor Function Exercises
Hydrotherapy
Assistive Mobility Devices
7. Tay-Sachs Disease Treatment Market Regional And Country Analysis
7.1. Global Tay-Sachs Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tay-Sachs Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tay-Sachs Disease Treatment Market
9.1. China Tay-Sachs Disease Treatment Market Overview
9.2. China Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tay-Sachs Disease Treatment Market
10.1. India Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tay-Sachs Disease Treatment Market
11.1. Japan Tay-Sachs Disease Treatment Market Overview
11.2. Japan Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tay-Sachs Disease Treatment Market
12.1. Australia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tay-Sachs Disease Treatment Market
13.1. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tay-Sachs Disease Treatment Market
14.1. South Korea Tay-Sachs Disease Treatment Market Overview
14.2. South Korea Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tay-Sachs Disease Treatment Market
15.1. Western Europe Tay-Sachs Disease Treatment Market Overview
15.2. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tay-Sachs Disease Treatment Market
16.1. UK Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tay-Sachs Disease Treatment Market
17.1. Germany Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tay-Sachs Disease Treatment Market
18.1. France Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tay-Sachs Disease Treatment Market
19.1. Italy Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tay-Sachs Disease Treatment Market
20.1. Spain Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tay-Sachs Disease Treatment Market
21.1. Eastern Europe Tay-Sachs Disease Treatment Market Overview
21.2. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tay-Sachs Disease Treatment Market
22.1. Russia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tay-Sachs Disease Treatment Market
23.1. North America Tay-Sachs Disease Treatment Market Overview
23.2. North America Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tay-Sachs Disease Treatment Market
24.1. USA Tay-Sachs Disease Treatment Market Overview
24.2. USA Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tay-Sachs Disease Treatment Market
26.1. South America Tay-Sachs Disease Treatment Market Overview
26.2. South America Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tay-Sachs Disease Treatment Market
27.1. Brazil Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tay-Sachs Disease Treatment Market
28.1. Middle East Tay-Sachs Disease Treatment Market Overview
28.2. Middle East Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tay-Sachs Disease Treatment Market
29.1. Africa Tay-Sachs Disease Treatment Market Overview
29.2. Africa Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tay-Sachs Disease Treatment Market Competitive Landscape And Company Profiles
